Adaptations of CrMS instruction for physiologically distinct reproductive states — including breastfeeding, post-hormonal contraceptive use, long or irregular cycles, and premenopause — are described with specific observational guidance for each context. These special protocols extend the clinical reach of the CrMS to all phases of a woman's reproductive life and ensure that charting remains interpretable even when cycle dynamics are atypical.
how to chart fertility after stopping birth control, can you get pregnant while breastfeeding before period returns, Creighton Model special instructions breastfeeding postpartum, what is a double peak in fertility charting, how to tell seminal fluid from fertile cervical mucus, fertility charting after miscarriage or abortion, Creighton Model infertility cycle timing diagnostic tests, premenopause fertility charting irregular cycles
Cite this article
Hilgers, T. W. (2004). Chapter 10: Special Instructions and Applications. The Medical and Surgical Practice of NaProTECHNOLOGY, 185-206.
Hilgers TW. Chapter 10: Special Instructions and Applications. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:185-206.
Hilgers, T. W. "Chapter 10: Special Instructions and Applications." The Medical and Surgical Practice of NaProTECHNOLOGY, 2004, pp. 185-206.
Related articles
Fertility AwarenessScientific FoundationsBiophysical Properties and Mucus TypingHormonal and Ultrasound Correlation
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The CREIGHTON MODEL FertilityCare System (CrMS) rests on a decades-long body of research demonstrating that cervical mucus functions as a physiologically regulated biological valve, opening predictably at the periovulatory estrogen rise and closing in the post-Peak phase. Chapter 15 of Hilgers (2004) synthesizes hormonal, ultrasound, cytologic, and biophysical evidence to establish that a woman's external observation of her Peak Day reliably identifies the fertile window, and documents the system's effectiveness data for both achieving and avoiding pregnancy across a five-study meta-analysis of nearly 1,900 couples.
PCOSEpidemiology and PrevalenceMetabolic ReframeDefective Ovulatory Events
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
PCOS (polycystic ovary syndrome), increasingly designated PMOS (polycystic metabolic ovary syndrome) to reflect its metabolic complexity, is far more prevalent than its classic presentation suggests, affecting roughly six percent of reproductive-age women and carrying systemic consequences well beyond fertility disruption. This chapter from the foundational NaProTECHNOLOGY textbook maps the hormonal architecture of the condition, its ovulatory defect patterns, its frequent co-occurrence with endometriosis, and the restorative surgical and cycle-tracking approaches developed at the Pope Paul VI Institute.
Andrology/Male FactorCriteria and ClassificationMedical TreatmentSurgical Correction
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Male infertility plays a clinically significant role in a large share of couples who struggle to conceive, yet standard laboratory criteria for semen analysis were designed primarily to predict success with assisted reproduction, not natural fertility. NaProTECHNOLOGY approaches male factor as a diagnosable condition with identifiable root causes, applying medical and surgical options aimed at restoring sperm function and combining that work with fertility-awareness charting to maximize the couple's chances of natural conception.
Progesterone safety in pregnancyCongenital anomaly risk and progesterone supportNatural progesterone versus synthetic progestins teratologyNaProTechnology pregnancy management
Thomas W. Hilgers, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Luteal phase and early pregnancy progesterone supplementation protocols are detailed, including indications derived from Creighton Model hormone profiles and dosing regimens for intramuscular and vaginal routes. Targeted progesterone support addresses a correctable physiological deficit identified through CrMS-guided monitoring, reducing early pregnancy loss in women with documented luteal insufficiency.